Abstract Library

#3502 Lifestyle and neuroendocrine tumor (NET) development

Introduction: There has been increasing interest in the relationship between lifestyle and NET. However, no review focusing solely on lifestyle as a risk factor for NET has previously been performed.

Conference:

Presenting Author: Bogaards M

Authors: Bogaards M, May A, Hassan F, Valk G, van Leeuwaarde R,

Keywords: neuroendocrine tumor, smoking, alcohol, diet, physical activity, body mass index, lifestyle,

#3186 Bronchopulmonary neuroendocrine tumors (bpNET) - A comparison of three subgroups

Introduction: bpNET are a rare malignancy of the lung, that arise sporadically (sp-bpNET), in the context of Multiple Endocrine Neoplasia Type 1 (MEN1) syndrome, or in the context of Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia (DIPNECH). Until now, bpNET of any type are regarded as similar entities. Clinically however, bpNET within MEN1 or DIPNECH rarely metastasize or lead to bpNET related death.

Conference: 18th Annual ENETS Concerence (2021)

Presenting Author: Levy S

Authors: Levy S, van den Broek M, Dijke K, Hartemink K, van Leeuwaarde R,

Keywords: bpNET, MEN1, DIPNECH,

#2122 Is the EORTC QLQ-QNET21 Optimal for Patients with Neuroendocrine Tumors?

Introduction: Quality of life (QoL) is important to all cancer patients. The EORTC QLQ-QNET21 is the most commonly used questionnaire in patients with neuroendocrine tumors (NETs).

Conference: 15th Annual ENETSConcerence (2018)

Presenting Author: van Leeuwaarde R

Authors: Van Leeuwaarde R, Spada F, Cheung W, Gonzalez-Clavijo A, Pracht M,

Keywords: Quality of life, GEP-NET, EORTC QLQ-GINET21,

#1858 Quality of Life in Patients with Multiple Endocrine Neoplasia Type I (MEN1): Results from the Dutch MEN1 Study Group

Introduction: Multiple Endocrine neoplasia type 1 (MEN1) is a hereditary tumor syndrome, characterized by an increased lifetime risk of benign and malignant endocrine tumors in various organs. Data on quality of life (QoL) in patients with MEN1 are scarce, whereas QoL is considered an important treatment outcome.

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author: Van Leeuwaarde R

Authors: Van Leeuwaarde R, Beijers H, de Herder W, Dekkers O, Van der Horst-Schrivers A,

Keywords: MEN1, QoL,